Endostatin (Recombinant mouse, 100 μg/ml; Alpha Diagnostic, San Antonio, TX), a VEGF-independent angiogenesis inhibitor, was injected subcutaneously daily during days 5–15 after stroke to hcV-treated mice. hcV-Endostatin mice were submitted to behavioral tests and their brain used for immunohistology at 16 weeks time point.
Endostatin recombinant mouse
Manufactured by Alpha Diagnostic
Endostatin (Recombinant mouse) is a protein produced through recombinant DNA technology. It is a naturally occurring angiogenesis inhibitor that helps regulate the formation of new blood vessels.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using endostatin recombinant mouse
1
Post-Stroke Endostatin Treatment
2
Post-Stroke Endostatin Treatment
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Endostatin (Recombinant mouse, 100 μg/ml; Alpha Diagnostic, San Antonio, TX), a VEGF-independent angiogenesis inhibitor, was injected subcutaneously daily during days 5–15 after stroke to hcV-treated mice. hcV-Endostatin mice were submitted to behavioral tests and their brain used for immunohistology at 16 weeks time point.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!